Kelly Ishida

2.4k total citations
79 papers, 1.8k citations indexed

About

Kelly Ishida is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Kelly Ishida has authored 79 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 34 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Kelly Ishida's work include Antifungal resistance and susceptibility (45 papers), Fungal Infections and Studies (32 papers) and Nail Diseases and Treatments (13 papers). Kelly Ishida is often cited by papers focused on Antifungal resistance and susceptibility (45 papers), Fungal Infections and Studies (32 papers) and Nail Diseases and Treatments (13 papers). Kelly Ishida collaborates with scholars based in Brazil, United Kingdom and United States. Kelly Ishida's co-authors include Sônia Rozental, Cristina de Castro Spadari, Luciana B. Lopes, Celso Vataru Nakamura, Taissa Vila, João Carlos Palazzo de Mello, Wanderley de Souza, Diógenes Aparı́cio Garcia Cortez, Tânia Ueda‐Nakamura and Benedito Prado Dias Filho and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Applied Microbiology and Biotechnology.

In The Last Decade

Kelly Ishida

76 papers receiving 1.8k citations

Peers

Kelly Ishida
Kelly Ishida
Citations per year, relative to Kelly Ishida Kelly Ishida (= 1×) peers Alexandre Meneghello Fuentefría

Countries citing papers authored by Kelly Ishida

Since Specialization
Citations

This map shows the geographic impact of Kelly Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Ishida more than expected).

Fields of papers citing papers by Kelly Ishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Ishida. The network helps show where Kelly Ishida may publish in the future.

Co-authorship network of co-authors of Kelly Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Ishida. A scholar is included among the top collaborators of Kelly Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Ishida. Kelly Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishida, Kelly, et al.. (2025). Interaction of the SXT/R391 element ICE Pmi Jpn1 with its natural host Proteus mirabilis. Microbiology Spectrum. 13(7). e0033925–e0033925.
2.
Rodrigues, Clenilson Martins, Carolina Borsoi Moraes, Cecília Gomes, et al.. (2024). A potential antiviral against COVID-19 obtained from Byrsonima coccolobifolia leaves extract. Fitoterapia. 173. 105820–105820. 2 indexed citations
3.
Pelisson, Marsileni, Marcelle de Lima Ferreira Bispo, Ricardo Sérgio Almeida, et al.. (2024). Geraniol Potentiates the Effect of Fluconazole against Planktonic and Sessile Cells of Azole-Resistant Candida tropicalis: In Vitro and In Vivo Analyses. Pharmaceutics. 16(8). 1053–1053. 3 indexed citations
4.
Ferreira, Marcelo J. P., Ângela Lúcia Bagnatori Sartori, Clenilson Martins Rodrigues, et al.. (2024). Exploring antifungal potential: The flavonoid composition of Machaerium villosum extracts against Cryptococcus neoformans. Research Society and Development. 13(1). e1613144604–e1613144604. 1 indexed citations
5.
Barbosa, Eduardo José, et al.. (2024). Niclosamide nanoemulsion for colorectal cancer: development, physicochemical characterization, and in vitro anticancer activity. Journal of Nanoparticle Research. 26(9). 2 indexed citations
6.
Ishida, Kelly, et al.. (2023). Crystal structure of dihydrofolate reductase from the emerging pathogenic fungus Candida auris. Acta Crystallographica Section D Structural Biology. 79(8). 735–745. 1 indexed citations
7.
Spadari, Cristina de Castro, Luana Pereira Borba-Santos, Sônia Rozental, & Kelly Ishida. (2023). Miltefosine repositioning: A review of potential alternative antifungal therapy. Journal de Mycologie Médicale. 33(4). 101436–101436. 6 indexed citations
8.
Ishida, Kelly, Gerson Nakazato, Phileno Pinge‐Filho, et al.. (2023). Synergistic Antifungal Interaction between Pseudomonas aeruginosa LV Strain Metabolites and Biogenic Silver Nanoparticles against Candida auris. Antibiotics. 12(5). 861–861. 9 indexed citations
9.
Salata, Giovanna Cassone, Alexsandra Conceição Apolinário, Kelly Ishida, et al.. (2023). Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase. European Journal of Pharmaceutical Sciences. 192. 106635–106635. 5 indexed citations
10.
Knirsch, Marcos Camargo, et al.. (2023). Unveiling the optimal path: High-pressure homogenization and D-phase emulsification methods for borage oil nanoemulsion design. Industrial Crops and Products. 208. 117853–117853. 3 indexed citations
11.
Spadari, Cristina de Castro, et al.. (2023). Oral delivery of brain-targeted miltefosine-loaded alginate nanoparticles functionalized with polysorbate 80 for the treatment of cryptococcal meningitis. Journal of Antimicrobial Chemotherapy. 78(4). 1092–1101. 11 indexed citations
12.
Spadari, Cristina de Castro, et al.. (2022). Ketoconazole/calix[n]arenes-based compounds improve the antifungal activity against azole-resistant Candida isolates. Journal de Mycologie Médicale. 32(2). 101254–101254. 2 indexed citations
13.
Wirth, Fernanda, et al.. (2022). Experimental Models for Pharmacokinetic and Pharmacodynamic Studies of Antifungals Used in Cryptococcosis Treatment. Future Microbiology. 17(12). 969–982. 1 indexed citations
14.
Lourenço, Felipe Rebello, et al.. (2022). Besifloxacin Nanocrystal: Towards an Innovative Ophthalmic Preparation. Pharmaceutics. 14(10). 2221–2221. 8 indexed citations
15.
Ishida, Kelly, et al.. (2019). Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis. SHILAP Revista de lepidopterología. 6 indexed citations
16.
Spadari, Cristina de Castro, et al.. (2019). <p>Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis</p>. International Journal of Nanomedicine. Volume 14. 5187–5199. 100 indexed citations
17.
Borba-Santos, Luana Pereira, Gonzalo Visbal, Anderson Messias Rodrigues, et al.. (2016). Δ24-Sterol Methyltransferase Plays an Important Role in the Growth and Development of Sporothrix schenckii and Sporothrix brasiliensis. Frontiers in Microbiology. 7. 311–311. 19 indexed citations
18.
Vila, Taissa, Kelly Ishida, Sérgio Henrique Seabra, & Sônia Rozental. (2016). Miltefosine inhibits Candida albicans and non-albicans Candida spp. biofilms and impairs the dispersion of infectious cells. International Journal of Antimicrobial Agents. 48(5). 512–520. 39 indexed citations
19.
Ishida, Kelly, et al.. (2013). Characterization of Candida spp. isolated from vaginal fluid: identification, antifungal susceptibility, and virulence profile. Redalyc (Universidad Autónoma del Estado de México). 35(1). 1–8. 1 indexed citations
20.
Ishida, Kelly, et al.. (2009). FREQUÊNCIA DE LEVEDURAS EM EXAMES COLPOCITOLÓGICOS OFERECIDOS PELO SUS EM DUAS CIDADES DO NORTE PARANAENSE. 4(2). 467–467.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026